公司概述
Universal Health Services, Inc. operates a network of acute care hospitals alongside outpatient and behavioral health care facilities located throughout the United States. The company is organized into two primary segments, specifically Acute Care Hospital Services and Behavioral Health Care Services, delivering comprehensive medical care. This entity functions within the Healthcare sector and falls under the Medical Care Facilities industry, positioning it as a core provider of essential health infrastructure. With a market capitalization of $11.41B and an annual revenue of $17.36B, the firm demonstrates substantial scale in the healthcare market. The company supports this operation with a workforce of 78,400 employees, indicating a large-scale organizational structure capable of managing complex healthcare delivery systems. These valuation and revenue figures suggest that UHS holds a significant position within the industry, reflecting both market trust and operational breadth.
财务健康
The financial performance metrics for the trailing twelve months reveal a revenue stream of $17.36B, net income of $1.49B, and EBITDA of $2.61B. The substantial gap between the $17.36B revenue and the $1.49B net income highlights a cost structure where operating expenses, including cost of goods sold and overhead, consume a significant portion of gross revenue. The company generated $565.25M in free cash flow, which provides a tangible measure of its financial flexibility to fund capital expenditures, reduce debt, or potentially increase dividends without relying solely on external financing. Margin analysis shows a gross margin of 43.9%, an operating margin of 11.5%, and a profit margin of 8.6%, indicating that while the company retains a healthy gross portion of sales, operational efficiencies are required to translate that into bottom-line profitability. Regarding liquidity and leverage, the company holds $137.80M in cash against total debt of $5.17B, resulting in a debt-to-equity ratio of 69.73% which characterizes a leveraged balance sheet rather than a conservative one. The current ratio stands at 1.05, suggesting that the company's current assets are only slightly higher than its current liabilities, indicating tight short-term liquidity management. Return on Equity is reported at 21.3% while Return on Assets is 8.3%, revealing that management is highly effective at generating returns for shareholders relative to the equity base, though asset efficiency is moderate given the heavy capital intensity of hospital operations.
估值评估
Valuation multiples for Universal Health Services, Inc. include a trailing P/E ratio of 8.08 and a forward P/E of 7.30. The difference between the trailing and forward P/E implies that the market expects earnings to grow faster than the current earnings rate, leading to a lower multiple in the future. The price-to-book ratio is 1.57, which indicates that the stock trades at a moderate premium over its book value, reflecting the intangible value of its hospital network and brand. Alternative valuation metrics such as a price-to-sales ratio of 0.66 and an EV/EBITDA of 6.34 suggest the company is valued at a discount relative to sales, potentially indicating undervaluation or concerns about future revenue expansion. Regarding price volatility, the stock has a 52-week high of $246.33 and a 52-week low of $152.33. Without a specific current price provided in the facts, the range defines the historical trading band within which the stock has fluctuated over the past year. The beta value is 1.29, meaning the stock exhibits higher price volatility relative to the broader market, moving approximately 29% more than the market index during periods of fluctuation.
Growth & Income
Growth metrics display a revenue growth rate of 9.1% year-over-year and an earnings growth rate of 42.7% year-over-year. The significant disparity where earnings growth vastly outpaces revenue growth implies that the company is benefiting from leverage, cost synergies, or margin expansion rather than solely top-line volume increases. As a dividend payer, the company offers a dividend yield of 0.4% with a payout ratio of 3.5%. This extremely low payout ratio suggests that the company retains the vast majority of its earnings for reinvestment into operations and growth rather than distributing cash to shareholders. Given the low payout ratio and the substantial gap between free cash flow and dividend payments, the current dividend distribution is highly sustainable given the company's earnings generation. Overall, the growth and income profile indicates a capital-return strategy focused on internal expansion and balance sheet strengthening rather than aggressive shareholder payouts.